1. Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines
    Wes Wheeler, CEO, and Ariette van Strien, Chief Commercial Officer for Marken explain the company’s personalized supply chain solutions for clinical trial materials and sensitive drug shipments worldwide. 
  2. Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing

    Richard Snyder, Ph.D., Chief Scientific Officer, Scott Jeffers, Ph.D., Associate Director of Technical Operations and Ying Cai, Ph.D., Associate Director of Manufacturing Sciences at Brammer Bio discuss transient transfection for vector production.

  3. Catalent Acquires Cook Pharmica

    The company gains sterile fill/finish operations to meet the rising demand for biologics.

  4. Russian Pharma Market Offers Great Potential for Local Manufacturers

    Renaud Bessière, Plant Manager, Servier Russia, explains the nation's market.

  5. FDA Approves First Biosimilar Treatment for Multiple Cancers

    Amgen’s Mvasi biosimilar is approved.

  6. Alliance Aims to Develop Novel Mass Spectrometry Sample Handling Technology

    GSK, AstraZeneca and Labcyte collaborate to combine acoustic liquid dispensing with mass spectrometry to reduce costs and cycle times.

  7. M+W Group on the Road to BIO: Ensuring Your Project’s Success
    Peter Cramer, AIA, NCARB, Vice President, Life Science Facility Design at M+W Group discusses the role of the process architect.
  8. Potential Breakthrough HIV/AIDS Intervention Developed

    Sanofi study demonstrates genetically engineered antibodies can target multiple sites in one molecule.

  9. Ajinomoto Althea Set to Open New Capacity in San Diego

    A new GMP production suite at the High Potency Products (HPP) facility is in the works.

  10. What New Technology Introduced Within the Last Year Have You Found to Have the Most Impact on Your Business?

    Experts weigh in on our industry roundtable.

  11. Building the Foundation of Japan’s Premier CDMO

    Jun Yokohama, President & CEO of Bushu Pharmaceuticals Ltd. and Toshio Yoshioka, President at Spera Pharma, Inc. discuss how the firm helps clients overcome barriers to entry.

  12. Mitigating Shortages of Injectable Drugs in the United States

    Marga Viñes, Business Development Manager at Grifols explains how to tackle drug shortages.

  13. Mergers & Acquisitions: Combining Market Segments

    Dago Caceres, Marketing Director, and Gary Lord, Global Strategic Marketing Director at The Dow Chemical Company, discuss the drivers behind the merger.

  14. Chinese Biopharmaceutical Company Acquires a Canada-Based CDMO

    3SBio, as part of a joint venture formed with CPE Funds, has acquired Canadian biologics CDMO Therapure Biopharma.

  15. New CDMO/CRO Collaboration Announced

    ReciPharm and Clinical Trial Consultants are launching a new service to facilitate first-in-human trials.

  16. Innovation and Partnership Through Experience and Acquisition
    Avara CEO Tim Tyson explains the company’s acquisition strategy.
  17. Moving Quality to the Forefront Brings Measurable Results

    Chris Curtin, Executive Vice President and Chief Operating Officer of UPM Pharmaceuticals explains the implementation of Manufacturing Quality Assurance (MQA).

  18. GSK Shingles Vaccine Recommended for Approval by FDA Panel
    Shingrix would be the only other treatment for shingles approved in the US.
  19. Focusing on Clinical and Research Services

    Julia Sardayan, Director of Corporate Development at Smooth Drug Development explains plans for the company going forward.

  20. New Organ-On-A-Chip Designed to Model Influenza Virus Infections

    Researchers will use the technology to identify new drug targets and therapies.

MOST VIEWED THIS MONTH
The Road To BIO: An Epic Journey
View All
Take the Road to BIO
Our team went on the journey of a lifetime this summer, driving from Cambridge, Massachusetts to San Diego, California in a Lamborghini Aventador. Read on and relive their trip from start to finish.
Pharma's Almanac TV
View All Video

Attracting Investors and Shortening Development Times

James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)

Providing a Complete Modular Solution

George Wiker, Executive Director, AES

Bringing Bioscience to Space

Bill Goodman, Ph.D., Vice President, SCORPIO-V, a Division of HNu Photonics
Devin Ridgley, Project Scientist, SCORPIO-V, a Division of HNu Photonics

Harmonizing Development Internationally

Trishul Shah, Associate Director of Business Development, Polypeptide Group

PAO-M09-17-NI-031

Potential Breakthrough HIV/AIDS Intervention Developed

Sep 26, 2017 1:02:57 PM Innovation
Innovation

Alliance Aims to Develop Novel Mass Spectrometry Sample Handling Technology

Sep 26, 2017 1:00:34 PM PAO-M09-17-NI-031
Biosimilar

FDA Approves First Biosimilar Treatment for Multiple Cancers

Sep 26, 2017 12:57:45 PM PAO-M09-17-NI-030
Capacity Expansion

Ajinomoto Althea Set to Open New Capacity in San Diego

Sep 26, 2017 12:53:26 PM PAO-M09-17-NI-029
Acquisition

Catalent Acquires Cook Pharmica

Sep 26, 2017 12:48:29 PM PAO-M09-17-NI-028

GSK Shingles Vaccine Recommended for Approval by FDA Panel

Sep 21, 2017 2:50:43 PM PAO-M09-17-NI-027
CDMO CRO

New CDMO/CRO Collaboration Announced

Sep 21, 2017 2:45:18 PM PAO-M09-17-NI-026
Innovation

New Organ-On-A-Chip Designed to Model Influenza Virus Infections

Sep 21, 2017 2:05:50 PM PAO-M09-17-NI-025
  • CDMO
  • Acquisition

Chinese Biopharmaceutical Company Acquires a Canada-Based CDMO

Sep 21, 2017 2:00:55 PM PAO-M09-17-NI-024
Injectables

Mitigating Shortages of Injectable Drugs in the United States

Sep 20, 2017 4:47:40 PM PAO-M09-17-Cl-001
Clinical Trials

Findings Suggest Low-Cal Sweeteners Pose No Increased Diabetes Risk

Sep 19, 2017 2:30:15 PM PAO-M09-17-NI-023
Innovation

FDA Green Lights Mobile App to Help Treat Drug Abuse

Sep 19, 2017 12:55:20 PM PAO-M09-17-NI-022
Big Data

Big Data Alliance Aims to Advance Cancer Treatments

Sep 19, 2017 12:49:52 PM PAO-M09-17-NI-021
Clinical Trials

GSK and Innoviva Present Positive Results from Pioneering Asthma Study

Sep 19, 2017 12:46:59 PM PAO-M09-17-NI-020
ADC

Pfizer Gets Second ADC Approval in 2017

Sep 15, 2017 2:14:36 PM PAO-M09-17-NI-019
Expansion

Alcami Establishes New Center of Excellence

Sep 15, 2017 2:11:18 PM PAO-M09-17-NI-018
Expansion

Baxter Expands Generic Injectables Portfolio with Claris Injectables Acquisition

Sep 15, 2017 2:07:16 PM PAO-M09-17-NI-018
Serialization

UPM Pushes Forward with Serialization Efforts

Sep 15, 2017 2:00:01 PM PAO-M09-17-NI-017
Drug Delivery

Perfusion Appears to be Gaining Traction in Biopharma Manufacturing

Sep 14, 2017 4:31:28 PM POP-M08-17-NI-001
API

Becoming Bioavailable

Sep 14, 2017 4:18:29 PM MCO-M07-17-NI-021
Columns

In
Conversation

Mergers & Acquisitions: Combining Market Segments
Nice insight is in conversation with Dago Caceres, marketing director, and Gary Lord, global strategic marketing director at the Dow Chemical Company.

Design Logic

Marken: Stronger Than Ever
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.

Nice Insight Overview

Pharma Contract Services Consolidation Wave Continues

Nigel Walker, That's Nice/Nice Insight
//Fix for text overflow in cards